BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/27/2022 1:00:17 PM | Browse: 531 | Download: 1760
Publication Name World Journal of Clinical Cases
Manuscript ID 76958
Country China
Received
2022-04-24 15:34
Peer-Review Started
2022-04-22 04:45
First Decision by Editorial Office Director
2022-06-08 08:54
Return for Revision
2022-06-08 08:54
Revised
2022-06-17 12:16
Publication Fee Transferred
Editorial Processing by Scientific Editor
2022-08-22 03:09
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2022-08-25 20:45
Articles in Press
2022-08-25 20:45
Edit the Manuscript by Language Editor
Typeset the Manuscript
2022-09-14 08:28
Publish the Manuscript Online
2022-09-27 13:00
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Pharmacology & Pharmacy
Manuscript Type Case Report
Article Title Tislelizumab-related enteritis successfully treated with adalimumab: A case report
Manuscript Source Unsolicited Manuscript
All Author List Na Chen, Min-Jia Qian, Ru-Hui Zhang, Qi-Qi Gao, Chao-Chao He, Ya-Ke Yao, Jian-Ying Zhou and Hua Zhou
ORCID
Author(s) ORCID Number
Ru-Hui Zhang http://orcid.org/0000-0002-1553-8538
Jian-Ying Zhou http://orcid.org/0000-0002-8924-935X
Hua Zhou http://orcid.org/0000-0001-6397-3203
Funding Agency and Grant Number
Corresponding Author Hua Zhou, MD, Associate Chief Physician, Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Qingchun Road 79, Hangzhou 310003, Zhejiang Province, China. zhouhua1@zju.edu.cn
Key Words Tislelizumab; Adalimumab; Enteritis; Case report
Core Tip A patient with advanced lung cancer who developed diarrhea after receiving tislelizumab combined with pemetrexed and carboplatin, with poor response to glucocorticoid treatment. The symptoms were significantly improved after the use of adalimumab 10 mg, subcutaneous injection, every 2 wk for 3 times. Colonoscopy and intestinal mucosal pathology suggested improvement.
Publish Date 2022-09-27 13:00
Citation Chen N, Qian MJ, Zhang RH, Gao QQ, He CC, Yao YK, Zhou JY, Zhou H. Tislelizumab-related enteritis successfully treated with adalimumab: A case report. World J Clin Cases 2022; 10(28): 10186-10192
URL https://www.wjgnet.com/2307-8960/full/v10/i28/10186.htm
DOI https://dx.doi.org/10.12998/wjcc.v10.i28.10186
Full Article (PDF) WJCC-10-10186.pdf
Full Article (Word) WJCC-10-10186.docx